u/Buy-NVDA

So drive a c6 grand sport automatic with 27000 miles and absolutely love her I think she's the most beautiful car and enjoy driving her as my daily. I'm considering doing a ton of mods mainly for reliability but also for a power boost, this is the list of stuff the shop would be doing it will cost me 16k with labor. My fear is that I know it won't add 16k in value to the car and I have trouble throwing away so much money even though I know I will love it. Has anyone done something similar and can you share how it has been for you? Or have any other recommendations? I bought it for 36k so I will be in it for 52k which seems insane but maybe I'm just being dramatic. She is also mechanically perfect and I've never had a single issue with her in the 6k miles I have done sense buying. Any advice is appreciated here is a list of all the mods/maintenance that the shop would be doing.

Kooks long-tube headers
High-flow cats / X-pipe
QTP cutouts / mid-pipe cutouts, if that’s what you meant by “mid pipe ports”
Mild camshaft
DeWitts radiator

Engine / cam support
SFI harmonic balancer — ATI
ARP balancer bolt
Upgraded timing chain
Oil pump upgrade or fresh OEM/Melling pump
Valve stem seals while springs are being changed
Rocker trunnion upgrade
Correct pushrod length verification
PAC valve springs matched to the cam
Hardened pushrods
Front main seal
Timing cover gasket
Water pump gaskets or full water pump replacement
Cooling / drivetrain protection
Auxiliary transmission cooler for the 6L80E
6L80E pan-drop/filter service with Dexron VI
Correct DeWitts automatic-trans radiator fittings
Fresh coolant / coolant flush
Thermostat replacement,
Radiator hoses inspection or replacement

Heat protection
Starter heat shield / thermal blanket
Plug-wire heat sleeves or boot protection
Heat shielding around QTP wiring, tunnel, brake lines, trans lines, and nearby harnesses
Intake / PCV / tune
Halltech Killer Bee intake, if you are keeping the intake in the build
Closed-loop catch can, Mighty Mouse
Conservative dyno tune
Earlier fan settings
Safe air/fuel and timing
Keep reasonable trans torque management
Keep cats/rear O2 readiness as inspection-friendly as possible
Exhaust / cutout details
QTP low-profile oval cutouts
Wireless remote/controller
Custom welding into the X-pipe
Placement focused on ground clearance, heat, and serviceability

I’m just college student who has spent more time reading biotech clinical trial protocols than studying for my exams. I’m $30k+ deep into this. I am a regard, and this is a casino. And yeah this is written by ai but its my research im lazy and not getting paid to write this sue me.

The TL;DR
Viridian Therapeutics ($VRDN) just dropped god-tier Phase 3 data (REVEAL-2), gap-up pumped the stock, and then immediately "upsized" a capital raise to build a $1.1 BILLION liquid to push their new drug. The banks just bought millions of shares at $17.00 and cant sell until $26. Right now, the stock is trading at $16.89. You can literally buy the dip cheaper than the billionaires did.
1. The Data:
Last week, VRDN released results for their TED drug (Chronic Thyroid Eye Disease).
• The Result: p < 0.0001. They didn't just beat the placebo; they vaporized it.
• The Competition: They are coming for Amgen’s Tepezza (a multi-billion dollar monopoly). VRDN’s drug is safer, has way fewer side effects (no hearing loss), and is building an at-home injector so patients don't have to sit in a hospital chair for 4 hours.
• The Outcome: This is "Best-in-Class" medicine. Period.
2. The "Institutional Floor" (Buying Below the Banks)
• The Offering: They just closed an upsized $350 MILLION raise today.
• The Price: The institutions (the people who actually know how to read balance sheets) just agreed to buy at $17.00.
• The Arbitrage: We are currently trading BELOW the offering price. Usually, retail is the "exit liquidity" for the banks. This time, the banks are the floor for us.
• The Convertible Clue: They issued notes with a conversion price of $24.65. The banks are literally betting $225M that this stock hits $25+ in the near future.
3. The Catalyst: JUNE 30 MOONSHOT 🌙
The REVEAL-2 data was just the appetizer. The real play is the June 30 PDUFA date for their lead drug, Veligrotug.
• Priority Review: The FDA is fast-tracking this.
• The Setup: With $1.1B in cash, VRDN is "uncrashable." They are fully funded for a global launch. If the FDA says "Yes" on June 30, this stock doesn't just go to $20; it hits the analyst targets of $34.00+.

Check my profile if u think this is my first time spotting a moon shot. Will answer any questions in the comments.